Proinsulin C-peptide increases nitric oxide production by enhancing mitogen-activated protein-kinase-dependent transcription of endothelial nitric oxide synthase in aortic endothelial cells of Wistar rats

被引:86
作者
Kitamura, T
Kimura, K [1 ]
Makondo, K
Furuya, DT
Suzuki, M
Yoshida, T
Saito, M
机构
[1] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Biochem Lab, Sapporo, Hokkaido 0600818, Japan
[2] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kyoto, Japan
基金
日本学术振兴会;
关键词
actinomycin D; C-peptide; endothelial cells; eNOS; ERK; L-NAME; MAPK; nitric oxide; p38MAPK; proinsulin;
D O I
10.1007/s00125-003-1232-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis. Recent studies have suggested that proinsulin C-peptide improves vascular functions, possibly through nitric oxide (NO) production. To clarify the molecular mechanisms of vascular NO production induced by C-peptide, we examined the effects of C-peptide on NO production and NO synthase expression in rat aortic endothelial cells in connection with mitogen-activated protein kinase (MAPK) activation. Methods. Aortic endothelial cells were isolated from female Wistar rats, cultured to confluence, and serum-starved for 24 h before treatment with C-peptide. Nitric oxide production was measured by the DAF-2 fluorescence dye method and relative amounts of endothelial nitric oxide synthase (eNOS) protein and its mRNA were semi-quantified by western blot and RT-PCR analyses respectively. Activation of MAPK was estimated by western blot detection of activity-related phosphorylation and in vitro kinase assay. Results. Stimulation of cells with C-peptide for 3 h doubled NO production, which was suppressed by the NO synthase inhibitor, N-G-nitro-L-arginine methyl ester (L-NAME). Stimulation also increased mRNA and protein contents of eNOS in a manner sensitive to the transcription inhibitor actinomycin D. It did not affect inducible NO synthase mRNA. C-peptide also induced rapid phosphorylation and activation of extracellular signal-regulated kinase (ERK, also known as p44/42MAPK), but not of p38MAPK. In cells pretreated with the ERK inhibitor PD98059 the C-peptide-elicited increase of NO production and eNOS was abrogated in a dose-dependent manner; suppression of ERK phosphorylation induced by C-peptide also occurred. Conclusions/interpretation. Our results show that C-peptide increases NO production by increasing eNOS protein contents through ERK-dependent up-regulation of eNOS gene transcription. This could explain some actions of C-peptide on the vasculature, indicating a pivotal role for C-peptide in vascular homeostasis.
引用
收藏
页码:1698 / 1705
页数:8
相关论文
共 37 条
  • [1] Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells
    Bouloumié, A
    Schini-Kerth, VB
    Busse, R
    [J]. CARDIOVASCULAR RESEARCH, 1999, 41 (03) : 773 - 780
  • [2] Transcriptional regulation of endothelial nitric-oxide synthase by an interaction between casein kinase 2 and protein phosphatase 2A
    Cieslik, K
    Lee, CM
    Tang, JL
    Wu, KK
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (49) : 34669 - 34675
  • [3] CURTIS ASG, 1982, ADV EXP MED BIOL, V149, P193
  • [4] Effects of C-peptide on forearm blood flow and brachial artery dilatation in patients with type 1 diabetes mellitus
    Fernqvist-Forbes, E
    Johansson, BL
    Eriksson, MJ
    [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 2001, 172 (03): : 159 - 165
  • [5] Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus
    Forst, T
    Kunt, T
    Pohlmann, T
    Goitom, K
    Engelbach, M
    Beyer, J
    Pfützner, A
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (10) : 2036 - 2041
  • [6] Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I
    Forst, T
    De la Tour, DD
    Kunt, T
    Pfützner, A
    Goitom, K
    Pohlmann, T
    Schneider, S
    Johansson, BL
    Wahren, J
    Löbig, M
    Engelbach, M
    Beyer, J
    Vague, P
    [J]. CLINICAL SCIENCE, 2000, 98 (03) : 283 - 290
  • [7] Fulton D, 2001, J PHARMACOL EXP THER, V299, P818
  • [8] Cellular regulation of endothelial nitric oxide synthase
    Govers, R
    Rabelink, TJ
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2001, 280 (02) : F193 - F206
  • [9] Molecular basis for the insulinomimetic effects of C-peptide
    Grunberger, G
    Qiang, X
    Li, Z
    Mathews, ST
    Sbrissa, D
    Shisheva, A
    Sima, AAF
    [J]. DIABETOLOGIA, 2001, 44 (10) : 1247 - 1257
  • [10] Honing MLH, 1998, DIABETES METAB REV, V14, P241, DOI 10.1002/(SICI)1099-0895(1998090)14:3<241::AID-DMR216>3.0.CO